OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CRBU

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Caribou Biosciences (CRBU) Earnings Date & Reports

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CRBU is expected to report earnings to fall 10.47% to -38 cents per share on August 12

Caribou Biosciences CRBU Stock Earnings Reports

Q2'25

Est.

$-0.38

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.04

The last earnings report on May 08 showed earnings per share of -43 cents, beating the estimate of -44 cents. With 658.70K shares outstanding, the current market capitalization sits at 160.90M.

View a ticker or compare two or three

Compare

CRBU

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CRBU
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRBU showed earnings on May 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2929 7th Street

Phone

+1 510 982-6030

Employees

158

Web

https://www.cariboubio.com